Claude Maraoui, President and Chief Executive Officer of Journey Medical, commented, “Ramsey’s promotion to COO reflects his exceptional leadership and the critical role he has played in our Company’s ...

The Labour manifesto pledged to “maximise our potential to lead the world in clinical trials”. With our regulatory advantage ...

It is commonplace for specific laws to govern specific aspects of a particular category of goods. Typically, there are ...

In 2025, the CNS market is forecast to surpass $80bn in sales for the first time since 2013, marking a significant turnaround ...

Esteve Pharmaceuticals, S.A. will commercialize Increlex in all markets outside the U.S.DEER PARK, Ill., April 01, 2025 ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

Naturally, Cigna's bulked-up service offerings should allow it to cross-sell traditional PBM and specialty pharmacy services into its managed-care client set and vice versa, opening up new profit ...

Q3 2025 Earnings Call Transcript March 28, 2025 ImmunoPrecise Antibodies Ltd. reports earnings inline with expectations.

The state’s second-largest insurer is grappling with heightened health care spending and a market that is increasingly unable ...

Reticulate Micro, Inc. ("Reticulate Micro" or the "Company") , a software products company specializing in advanced video compression technology, announced today that it will acquire the remaining ...

Beijing Time, Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics") announced that Merck has exercised the global commercialization option for pimicotinib (ABSK021), with an option exercise fee of ...

Southeast Asia is attracting record levels of foreign direct investment (FDI), even as global FDI declines. As Courtney ...